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Disrupted habenula function in major depression
RP Lawson1,2, CL Nord1, B Seymour3,4, DL Thomas5, P Dayan6, S Pilling7 and JP Roiser1
The habenula is a small, evolutionarily conserved brain structure that plays a central role in aversive processing and is hypothesised
to be hyperactive in depression, contributing to the generation of symptoms such as anhedonia. However, habenula responses
during aversive processing have yet to be reported in individuals with major depressive disorder (MDD). Unmedicated and
currently depressed MDD patients (N= 25, aged 18–52 years) and healthy volunteers (N= 25, aged 19–52 years) completed a
passive (Pavlovian) conditioning task with appetitive (monetary gain) and aversive (monetary loss and electric shock) outcomes
during high-resolution functional magnetic resonance imaging; data were analysed using computational modelling. Arterial spin
labelling was used to index resting-state perfusion and high-resolution anatomical images were used to assess habenula volume.
In healthy volunteers, habenula activation increased as conditioned stimuli (CSs) became more strongly associated with electric
shocks. This pattern was significantly different in MDD subjects, for whom habenula activation decreased significantly with
increasing association between CSs and electric shocks. Individual differences in habenula volume were negatively associated with
symptoms of anhedonia across both groups. MDD subjects exhibited abnormal negative task-related (phasic) habenula responses
during primary aversive conditioning. The direction of this effect is opposite to that predicted by contemporary theoretical
accounts of depression based on findings in animal models. We speculate that the negative habenula responses we observed
may result in the loss of the capacity to actively avoid negative cues in MDD, which could lead to excessive negative focus.
Molecular Psychiatry (2017) 22, 202–208; doi:10.1038/mp.2016.81; published online 31 May 2016
INTRODUCTION
Major depressive disorder (MDD) is associated with problems
exploiting affective information to guide goal-directed behaviour.1
Symptoms relating to motivational processing, such as anhedonia
and fatigue, result in poorer treatment prognosis,2,3 and standard
treatments for depression are relatively ineffective in ameliorating
them.4 The neurobiological mechanisms underlying motivational
symptoms in depression remain poorly understood; however,
contemporary theoretical accounts have suggested that they may
be driven by hyperactivity in the habenula,5 a small brain structure
adjacent to the medial dorsal (MD) thalamus that plays a central
role in negatively motivated behaviour.
The habenula is extensively connected with the dorsal and
medial raphe nuclei and ventral tegmental area (VTA), the sources
of the brain’s serotonin and dopamine neurons, respectively.6,7
The afferent and efferent connections of the habenula (outlined
comprehensively in a recent review8) suggest a route by which the
habenula might affect monoaminergic transmission and thereby
affective processing. Moreover, single-cell recording studies in
non-human primates have demonstrated that the lateral habenula
(LHb) responds to aversive stimuli,9 and that LHb stimulation
profoundly inhibits VTA dopamine neuron firing.10 Thus, when
habenula activity is high, dopamine activity is suppressed.
Furthermore, optogenetic work in rodents provides convincing
evidence that activating the habenula can promote various forms
of behavioural avoidance.11 Therefore, LHb dysfunction might
influence the processing of motivationally salient stimuli and
thereby result in abnormal affective experience and behaviour.
Evidence supporting a role for the LHb in MDD comes from
rodent models that use unavoidable aversive stimuli to induce
learned helplessness.12 LHb metabolism is elevated in learned
helplessness,13 and also in rats congenitally vulnerable to
this procedure even before aversive stimulation.14 More recent
studies have shown enhanced excitatory inputs to VTA-projecting
habenula neurons in learned helplessness models,15 and that both
elevated LHb spiking and depressive behaviours are reversed
following antidepressant treatment.16 In addition, a complete
stereotaxic pharmacological inhibition of the habenula has
been reported to ameliorate depressive-like behaviour in a model
of treatment-resistant depression.17 Furthermore, mice with
dorsal medial habenula lesions show difficulty with performing
motivation-based locomotor behaviours and show some depres-
sive phenotypes related to hedonic state.18 These rodent studies
suggest that habenula hyperactivity may contribute to depression,
specifically its motivational components, and indeed some
investigators have even tested whether deep brain stimulation
to this structure can relieve symptoms in humans.19,20 However,
direct evidence for habenula hyperactivity in human depressed
subjects is lacking.
Investigating the habenula noninvasively in humans poses a
methodological challenge. Post-mortem21 and structural imaging
data22 indicate that the human habenula is ∼ 15–30 mm3 in
volume, less than the size of a typical voxel in functional magnetic
resonance imaging (fMRI). In addition, standard pre-processing
steps including normalisation and substantial spatial smoothing
likely lead to localisation errors,23 making the signal from the
habenula difficult to resolve from neighbouring structures. An
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early positron emission tomography study reported that in
remitted MDD, Hamilton Depression Rating Scale (HAM-D) scores
following tryptophan depletion correlated with resting-state
blood flow in the vicinity of the habenula;24 consistent results
were observed in a subsequent study using arterial spin labelling
(ASL).25 Reduced habenula volume has also been reported in
female MDD subjects,22 and a recent study reported that habenula
glucose metabolism was decreased in MDD following ketamine
treatment.26 However, no study to date has directly compared
habenula function between currently depressed individuals and
healthy volunteers (HVs) or explored the association between
habenula structure or function and motivational processing.
In a recent experiment using computational modelling and
high-resolution fMRI, we demonstrated that in HVs the habenula
encodes the negative motivational value of conditioned stimuli
(CSs), with greater activation elicited as the expectation of
receiving a painful electric shock increases.27 Here we employed
the same procedure to test our primary hypothesis that the
habenula is phasically hyperactive (that is, in response to specific
stimuli) in MDD. We additionally acquired high-resolution cerebral
perfusion (ASL) images during the resting state to test our
secondary hypothesis that the habenula is tonically hyperactive
(that is, in the absence of specific external stimulation) in MDD. To
confirm prior reports of reduced habenula volume in MDD,22 we
quantified habenula volume on high-resolution anatomical
images. Finally, we assessed whether habenula function and
structure relate to the core motivational symptoms of depression
using measures of anhedonia and fatigue.
MATERIALS AND METHODS
Participants
A total of 27 individuals meeting DSM-IV (Diagnostic and Statistical Manual
of Mental Disorders, 4th Edition) criteria for MDD and 29 HVs group
matched for age, gender and intelligence quotient (assessed by the
Wechsler Test of Adult Reading) were recruited to participate in the study.
Following exclusions (see Supplementary Methods for details), 25 subjects
in each group were included in the analyses (males: MDD=15, HV = 14).
Demographic and clinical data are displayed in Table 1 and full
recruitment and exclusion criteria are included in the Supplementary
Methods. All participants provided written informed consent and were
compensated financially. The London Queen Square Research Ethics
Committee approved the study (reference 10\H0716\2).
Symptom measures
To assess motivational symptoms participants completed the Snaith–
Hamilton Pleasure Scale (SHAPS)28 and the Fatigue Severity Scale (FSS):29
on both scales, higher scores indicate more severe symptoms. General
depressive symptoms were assessed with the HAM-D30 and the Beck
Depression Inventory (BDI).31
Conditioning paradigm
During fMRI, subjects performed a Pavlovian conditioning task during
which they were passively exposed to seven CSs (abstract images) that
were followed by different reinforcing outcomes (with high or low
probability of reinforcement: win £1, lose £1 or painful electric shock, with
the non-reinforced outcome being neutral; or a guaranteed neutral
outcome) (Figure 1a and Supplementary Methods). During conditioning,
subjects performed a fixation cross-flicker detection task to ensure
attention (20% of trials, overlaid on CSs) that was independent of
reinforcement. Three blocks were performed with different CSs in
each block.
Preference task
After each conditioning block, subjects’ explicit knowledge of CS
associations was assessed using a preference task, involving forced
choices between pairs of CSs. See Supplementary Methods for further
details.
MRI acquisition and analysis
High-resolution (1.5 mm isotropic) fMRI data were acquired with a 3T
Magnetom TIM Trio scanner (Siemens Healthcare, Erlangen, Germany)
and analysed using Statistical Parametric Mapping (SPM8; www.fil.ion.ucl.
ac.uk/spm).
For the analysis of habenula responses, we used a model-based fMRI
approach27,32 exploiting a reinforcement learning algorithm (with a
predetermined learning rate of α= 0.5)33 to calculate the trial-by-trial
associative values of CSs that probabilistically predicted wins, losses and
shocks. We then used these values in the fMRI analysis as parametric
regressors whose onsets were time locked to the presentation of win, loss
and shock CSs. Win, loss and shock outcomes were modelled in separate
regressors. Flicker trials and any other trial on which subjects made a
response were modelled separately. Cardiac and respiration parameters
were also included as regressors to correct for physiological noise.
We ran our model-based fMRI analyses across a range of learning rates
(0.3–0.7) to ensure that our results were robust (Supplementary Results) as
recommended for model-based fMRI analyses.33 See Supplementary
Methods for further details relating to image acquisition, pre-processing
and analysis.
Because our central hypotheses relate to the habenula, and given the
small size of this structure, we manually defined regions of interest
on high-resolution anatomical scans for the left and right habenula in
each subject according to an established protocol23 (Supplementary
Methods).
Table 1. Characteristics of the participants
Measure HV
(n= 25)a
MDD
(n= 25)b
Significance
Age, mean (s.d.), years 27.44 (8.75) 27.76 (9.01) 0.90
Sex, n males 14/25 15/25
HAM-D, mean (s.d.) 1.64 (1.52) 19.08 (3.75) o0.001
BDI, mean (s.d.) 3.76 (4.13) 25.36 (8.94) o0.001
FSS, mean (s.d.) 26.60 (8.76) 45.92 (9.46) o0.001
SHAPS, mean (s.d.) 7.80 (6.35) 18.96 (7.02) o0.001
Wechsler Test of Adult 110.92 (5.15) 110.12 (7.54) 0.66
Reading predicted FSIQ,
mean (s.d.)
Average first-deg rel
with MDD, mean (s.d.)
NA 1.86 (1.30)
Average first-deg rel
treated, mean (s.d.)
NA 1.47 (1.25)
Age first episode,
mean (sd)
NA 18.16 (5.64)
Total no. of episodes,
mean (s.d.)
NA 2.88 (1.01)
Past antidepressant use, n NA 14/25
Years since last
medicated, mean (s.d.)
NA 6.6 (6.8)
Hospitalised for MDD, n NA 6/25
Attempted suicide, n NA 10/25
Average no. of suicide
attempts, mean (s.d.)
NA 1.08 (1.52)
Shock level, mA (s.d.) 0.45 (0.19) 0.43 (0.53) 0.86
% Missing resp (s.d.)–
conditioning task
3.14 (1.15) 4.17 (1.10) 0.52
Movement parameters
Sum absolute
translations, mm
12.80 (8.16) 10.03 (7.74) 0.30
Sum absolute rotation,
deg
13.31 (11.00) 10.27 (11.22) 0.44
Abbreviations: BDI, Beck Depression Inventory; deg, degree; FSIQ, Full
Scale Intelligence Quotient; FSS, Fatigue Sensitivity Scale; HAM-D, Hamilton
Rating Scale for Depression; HV, healthy volunteer; MDD, major depressive
disorder; NA, not available; rel, relative; resp, response; SHAPS, Snaith–
Hamilton Pleasure Scale. aA total of 23 in arterial spin labelling (ASL)
analysis. bA total of 22 in ASL analysis.
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ASL acquisition methods and processing
Cerebral blood flow (CBF) was measured using a pulsed ASL sequence.34
Raw CBF values were extracted from the habenula regions of interest of
each subject and normalised for average whole volume perfusion. Further
details are provided in the Supplementary Methods.
Statistical analysis
Behavioural and habenula data were analysed in SPSS 20 (IBM, Chicago, IL,
USA). All data were inspected before analysis to check for deviations from
Gaussian distributions. Differences between conditions were analysed
using repeated-measures analysis of variance with group as the between-
subjects factor. Planned comparisons were conducted using independent
samples t-tests (two tailed unless otherwise stated) between groups and
paired samples t-tests within groups. Where assumptions of heterogeneity
of covariance were violated, degrees of freedom were corrected using the
Greenhouse–Geisser approach. Relationships between habenula structure
and function and motivational symptoms were assessed using multiple
linear regression.
Power analysis
With 25 participants in the HV group we had 80% power to replicate the
effect we observed previously for habenula responses to parametric shock
CS values (d ~0.5)22 at α= 0.05 (one tailed). With 25 depressed participants
we had 80% power to detect a group difference of d ~ 0.8 at α= 0.05 (two
tailed).
RESULTS
Behaviour
We confirmed conditioning by measuring relative CS preference.
Consistent with our previous results, shock CSs were less preferred
than win and neutral CSs (main effect of CS type: F(2, 96.16) =
273.46, Po0.001). There was no group-by-stimulus interaction
(F(2, 96.16) = 0.85, P= 0.471) suggesting that MDD and control
participants learned the CS–outcome associations similarly
(Figure 1b).
Reaction times to respond to the fixation cross flicker were
longest on the negative (loss/shock) CS trials (main effect of CS
type: F(3, 144)= 3.68, P=0.014). The groups did not differ in terms
of overall reaction times (main effect of group: F(1, 48) = 0.22,
P=0.641; Figure 1c), but there was a significant group×CS type
interaction (F(3, 144)= 3.14, P=0.027). Planned comparisons
revealed that in both groups responses on win CS trials were faster
than on shock CS trials (HVs: t(24) = 3.30, P=0.003; MDD:
t(24) = 2.17, P=0.04). However, only the HVs responded faster on
win relative to neutral CS trials (conditioned invigoration:
t(24) = 3.97, P=0.001), with a trend towards a difference between
shock and neutral CS trials (conditioned suppression: t(24) = 1.75,
P=0.09). By contrast, MDD patients responded slower on shock
relative to neutral CS trials t(24) = 2.45, P=0.022), with no difference
between win and neutral CS trials (t(24) = 0.14, P=0.888).
Phasic (stimulus-evoked) habenula function
Next we analysed blood oxygen level-dependent (BOLD) signals in
the habenula (Figure 2a), at the time of the CS, corresponding to
computationally derived trial-by-trial fluctuation in CS values. The
resulting β-values represent the strength of the regression
coefficient relating changing CS value to habenula response.
A repeated-measures analysis of variance with hemisphere (left,
right) and CS type (win, lose, shock) as within-subjects factors and
group as a between-subjects factor revealed no main effect of
hemisphere (F(1, 48) = 2.05, P= 0.159), no CS type-by-hemisphere
interaction (F(2, 96) = 0.31, P= 0.735) and no group-by-CS type-by-
hemisphere interaction (F(2, 96) = 0.88, P= 0.735). We identified
no main effect of cue (F(2, 96) = 0.12, P= 0.883) and no main effect
of group (F(1, 48) = 0.97, P= 0.329), but there was a significant CS
type-by-group interaction (F(2, 96) = 4.02, P= 0.021).
Figure 1. Conditioning task and results. (a) Exemplar trial (a detailed description is provided in the main text). (b) Explicit preference scores for
win, loss, shock and neutral conditioned stimuli (CSs; maximum score of 24). (c) Reaction times to respond to fixation flickers overlaid on win,
loss, shock and neutral CSs. Pale-coloured bars represent major depressive disorder (MDD) patients and bright-coloured bars represent
healthy volunteers (HVs). Red and black solid lines show significant differences discussed in the text for the MDD and HV groups, respectively.
Beyond the results discussed in the text, there was a significant main effect of cue type in the HVs (F(2.06, 49.66)= 5.28, P= 0.002) and a trend
in the MDD group (F(3, 72)= 2.42, P= 0.073). Error bars show s.e.m. *Po0.05 and **Po0.001.
Disrupted habenula function in major depression
RP Lawson et al
204
Molecular Psychiatry (2017), 202 – 208
Planned comparisons demonstrated that the habenula
response to shock CS value in HVs was significantly greater than
in the MDD group (t(48) = 2.87, P= 0.006, Figure 2b). As expected,
the habenula response to parametrically varying shock CS value
was positive in HVs, and showed a trend towards differing from
zero (t(24) = 1.55, P= 0.066 (one tailed). Interestingly, two HVs
scored in the range for mild–moderate depression on the BDI
despite not fulfilling diagnostic criteria; and, when excluded, the
habenula response to shock CS value achieved statistical
significance (t(22) = 1.96, P= 0.03 (one tailed)). In other words, as
observed in our previous study in an independent sample of
HVs,27 the present data also show that as the CSs became more
shock predicting, the response in the habenula increased. By
contrast, habenula response to the value of shock CSs was
significantly negative in the MDD patients (t(24) = 2.67, P= 0.01).
Specifically, as the CSs became more shock predicting, the
response in the habenula decreased in MDD patients.
There was no group difference in habenula responses to win or
loss CS values (win: t(48) = 0.13, P= 0.891; loss: t(48) = 0.60,
P= 0.551). Consistent with our previous study, habenula responses
to win and loss CS values were not significantly different from zero
in HVs (win: t(24) = 0.03, P= 0.977; loss: t(24) = 0.54, P= 0.592), and
the same pattern was observed in MDD patients (win: t(24) = -0.22,
P= 0.829; loss t(24) = 0.27, P= 0.786). Exploratory voxel-wise
contrasts of group differences in responses to parametric win,
loss and shock CS values are presented in the Supplementary
Table S1.
MD thalamus responses
To exclude the possibility that signal from the MD thalamus,
a comparatively large structure adjacent to the habenula, could
be contributing to our effects we used the same bilateral
MD thalamus regions of interest as employed in our previous
investigation of the habenula in healthy volunteers.27 BOLD
responses to the computationally derived values of win, loss and
shock CSs were extracted from the left and right MD thalamus.
There was no main effect of CS type (F(2, 96) = 2.38, P= 0.097), no
main effect of hemisphere (F(1, 48) = 0.97) and no main effect of
group (F(1, 48) = 1.30, P= 0.25). Crucially the group-by-hemisphere
(Fo1), group-by-CS type (F(2, 96) = 1.10, P= 3.34), hemisphere-by-
CS type (Fo1) and three-way group-by-hemisphere-by-CS type
interactions (Fo1) were all nonsignificant.
Tonic (resting-state) habenula function
Average habenula raw CBF was 58.97 ml per 100 g per min (s.d.
15.71) in the MDD subjects and 56.71 ml per 100 g per min (s.d.
19.10) in the HVs. Analysis of CBF (corrected for whole volume
perfusion) revealed no main effect of hemisphere (F(1, 43) = 0.20,
P= 0.647), no main effect of group (F(1, 43) = 0.003, P= 0.954) and
no group-by-hemisphere interaction (F(1, 43) = 0.834, P= 0.366;
Figure 3a). Exploratory voxel-wise contrasts of group differences in
normalised CBF are presented in Supplementary Table S2.
Habenula structure
Average habenula volume was 20.83 mm3 (s.d. 7.31) in the MDD
patients and 22.31 mm3 (s.d. 9.29) in HVs. Analysis of habenula
volume, corrected for whole brain grey matter, revealed no main
effect of hemisphere (F(1, 50) = 0.148, P= 0.7), no main effect of
group (F(1, 50) = 0.091, P= 0.764) and no hemisphere-by-group
interaction (F(1, 50) = 1.05, P= 0.31; Figure 3b).
Relationship between habenula structure/function and
motivational symptoms
In order to test the hypothesis that habenula abnormalities drive
motivational symptoms in MDD we constructed two multiple
linear regression models, predicting anhedonia (SHAPS) and
fatigue (FSS) respectively. These models used habenula BOLD
Figure 2. Habenula functional and anatomical data. (a) Location of the habenula on coronal slices of a representative subject. (b) Habenula
response to the dynamically changing value of shock conditioned stimuli (CSs) is positive in healthy volunteers (HV) (bright red bar) and
negative in major depressive disorder (MDD) participants (pale red bar). For the other CSs, pale-coloured bars represent MDD patients and
bright-coloured bars represent HVs. These β-values represent the change in habenula response with increasing cue value. (c) The relationship
between normalised average habenula volume and symptoms of anhedonia (Snaith–Hamilton Pleasure Scale (SHAPS)) in MDD participants
(grey: r=− 0.36, P= 0.074) and HVs (black: r=− 0.41, P= 0.043). *Po0.07 (one tailed), **Po0.05 and ***Po0.001.
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responses to win, loss and shock CS values, normalised habenula
CBF and normalised habenula volume as predictors, and both
included group as a covariate. The model for SHAPS was
significant (F(6, 38) = 7.56, Po0.001, r2 = 0.544): group (patients
scored higher: t(44) = 4.96, Po0.001) and habenula volume
(negative: t(44) = 2.79, P= 0.008) were significant predictors of
anhedonia (higher anhedonia corresponding to smaller volume;
Figure 2c), with no other predictors approaching significance
(all Ps40.4). The group-by-habenula volume interaction was
nonsignificant (P40.5). The model for FSS was also significant
(F(6, 38 = 12.34, Po0.001, r2 = 0.661): group was a significant
predictor of fatigue (patients scored higher: t(44) = 6.98, Po0.001)
and there were trends for habenula CBF (positive: t(44) = 1.83,
P= 0.074) and habenula BOLD response to win CS value (negative:
t(44) = 1.70, P= 0.097), with no other predictors approaching
significance (all Ps40.6). The interactions with group were
nonsignificant (P40.1).
Exploratory post hoc analyses investigating the relationship
between habenula structure/function, general depressive symptoms
and behaviour are presented in the Supplementary Results.
DISCUSSION
The results of this study suggest that MDD participants have
abnormal phasic habenula responses elicited by cues that predict
upcoming punishment. This difference cannot be accounted for
by group differences in tonic habenula function or grey matter
volume. In addition, smaller habenula volume was associated with
greater anhedonic symptoms in both groups.
Phasic habenula function
Our task-related measurements confirm that, in HVs, as CSs
become more shock predicting, the habenula response
increases.27 Although we note that this effect narrowly missed
statistical significance in the full sample of HVs, our confidence in
this finding is bolstered not only by the fact that it replicates our
previous result in an independent sample,27 but also that when
we excluded two HVs who scored in the mild–moderate range for
depression on the BDI, the habenula response to shock CS value
achieved statistical significance. Surprisingly, however, in MDD
patients habenula responses decreased as CSs became more shock
predicting (Figure 2b). The effect size for this finding is large
(Cohen’s d for the group difference in habenula response to shock
CS value = 0.82), highly anatomically specific (pertaining only the
shock CS value cues in the habenula, and not the neighbouring
MD thalamus) and robust to changes in learning rates
(Supplementary Results).
This finding is contrary to hypotheses about phasic habenula
function in MDD derived from animal studies exploring tonic
habenula function that have been interpreted as indicating that
the habenula is hyperactive in depression.13,14 Recent studies in
rodents have shown that excitatory synapses on to VTA-projecting
LHb neurons are potentiated in learned helplessness,15 and one
study reported a shift towards enhanced GABA/glutamate ratio in
LHb synapses of rodents chronically treated with citalopram.35
Although these studies represent significant advances in under-
standing how animal LHb circuitry is altered by learned help-
lessness, to our knowledge there is currently no study directly
examining aversive stimulus-evoked habenula firing in animal
models of depression. We note that there is relevant work in
primates,36 although not in the context of models of depression,
and future work of this type assessing habenula responding
during behaviour will be crucial in bridging the gap between
human and animal research. However, it should be acknowledged
that we did not identify abnormal habenula resting-state
perfusion in MDD patients in the present study, although the
ASL measurements were always acquired after the conditioning
task, and it is therefore possible that perfusion may have been
affected by the prior aversive stimulation.
The surprising result that the habenula response to shock-
predicting CSs in MDD is in the opposite direction to that
identified in HVs across two studies requires substantial further
study. One possibility is that this opposite response leads to a loss
of capacity for active avoidance, specifically for primary punish-
ments. This suggestion is consistent with recent optogenetic
studies that demonstrate that activation of the LHb promotes
active behavioural avoidance of stimuli associated with negative
consequences.11,37 We note here that our behavioural data speak
only to passive avoidance (conditioned suppression) that does
seem to be spared in MDD (Figure 1b).
Consistent with our previous study,27 habenula responses to
win and loss CSs in HVs did not differ from zero in either group
(Figure 2b). Similarly, animal data suggest that the habenula is a
‘reward-negative’ brain region, predominantly concerned with
primary aversive outcomes and the cues that predict them.9 In
humans, negative feedback, as well as self-detected errors, have
been reported to increase BOLD response in the vicinity of the
habenula (although not yet measured at high resolution).38 In
further agreement, the only other high-resolution fMRI study of
the human habenula also failed to detect responses to reward
predicting CSs.39 Indeed, it is possible that in the present study
electric shocks (primary punishments) framed the task such that
all nonshock outcomes (that is, win and loss; secondary
reinforcers) were less motivationally salient, attenuating neural
responses to their associated CSs. In our previous investigation,
this interpretation was supported by pupil data, an implicit
measure of conditioning, which showed greater dilation for shock-
predictive CSs relative to all other CSs, despite explicit preference
scores showing no difference between the primary and secondary
punishments;27 however, in the present study we were unable to
collect pupil data because of time constraints in the scanner.
Should we interpret increased habenula BOLD activity as a mark
of increased activity of the output cells of the habenula? The
positive BOLD response to increasingly aversive CSs seen here
in HVs and also previously27 aligns with the spiking activity
of habenula neurons in non-human primates in response to
negative outcomes and cues that predict those outcomes.9
This would be consistent with the interpretation that opposite
habenula response, seen here in MDD, does indeed reflect
reduced habenula firing in response to the strength of shock-
predicting cues. However, the BOLD signal may reflect synaptic
input into a region,40 whereas animal research investigating
habenula function in learned helplessness has typically explored
efferent synaptic connections between the habenula and the
VTA.15 In addition, BOLD activity may reflect local inhibition,41 and
the relationship between BOLD response and spiking activity can
vary markedly across the brain.42 Furthermore, even with 1.5 mm
Figure 3. (a) Cerebral blood flow (CBF) values show no group
difference in resting-state habenula blood flow. (b) Habenula
volumes are not significantly different between the groups. Error
bars represent s.e.m. HV, healthy volunteer; MDD, major depressive
disorder.
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isotropic voxels, we do not have sufficient resolution to
disambiguate the medial and lateral portions of the habenula,
and it is possible that signal from the medial habenula contributes
to the disrupted response in MDD patients that we identified here.
In addition, rodent studies of gene expression in the habenula
reveal a striking variety of neuron types43 that may be
differentially affected in MDD and could affect the BOLD signal
in different ways. Indeed, even within the lateral portion of the
habenula there appears to be heterogeneity, as a very small
number of the cells there seem to drive the behaviours observed
in rodent models of depression.16 Nonetheless, high-resolution
fMRI offers the only noninvasive method to investigate the
function of this structure in humans, and provides a vital link from
animal models to clinical symptoms in humans. These results
highlight the need for greater synergy across human and animal
research and the integration of findings at both micro and macro
scales.
Tonic habenula function
A few previous studies in humans have suggested that the
habenula may be tonically hyperactive in MDD.24,25 By contrast,
we detected no group differences in normalised CBF as measured
by ASL (Figure 3a). We note that in both these previous reports
elevated habenula perfusion was identified only under conditions
of tryptophan depletion, complicating their interpretation. In
addition, neither of them was conducted at high resolution,
raising the possibility that perfusion measurements may have
been contaminated by nearby structures. A recent positron
emission tomography imaging study (with 6.5 mm resolution)
has shown decreased glucose metabolism in the vicinity of the
habenula following treatment with ketamine,26 and this is of
interest in light of two studies suggesting that ketamine
specifically ameliorates anhedonia, over and above the overall
improvement in depressive symptoms.44,45 However, energy
consumption in the brain reflects both inhibitory and excitatory
demands that cannot easily be differentiated by positron emission
tomography, and hence this finding does not conclusively speak
to the status of tonic habenula function in MDD. Finally, two
clinical case studies have reported remission of symptoms in
treatment-resistant depression following deep brain stimulation of
the habenula.19,20 In the latter study, increased metabolism
(measured by PET with 3.5 mm resolution) was apparent following
deep brain stimulation in the vicinity of the habenula after
6 months of stimulation. Therefore, on balance of all available
evidence to date, the hypothesis that increased tonic habenula
activity drives symptoms in MDD is not, at present, well supported
by either our current results or prior data in humans.
Habenula structure
A previous study examining differences in habenula volume
between MDD, bipolar depression (BD) and HVs reported lower
habenula volume in BD, and exploratory analyses identified
reduced habenula volume only in female MDD patients compared
with female HVs.22 Although a large proportion of our sample was
female, we did not find any group differences in habenula volume
(Figure 3b); that said, average habenula volume was numerically
lower in the MDD group than the HV group (mean: 1.99 mm3, s.e.:
2.36 mm3 difference). Interestingly, this numerical difference was
greater in females (mean: 2.41 mm3, s.e.: 2.95 mm3 difference). Our
study was not designed to assess this question, and this null result
should be interpreted with caution. Indeed, in order to detect a
difference in normalised habenula volume between female MDD
and healthy volunteers of the magnitude reported by Savitz
et al.22 (Cohen’s d ~ 0.53), we would have required 57 female
participants in each group to achieve 80% power.
Lower habenula volume was associated with symptoms of
anhedonia in both groups in our sample (Figure 2c). However, we
did not specifically aim to recruit an anhedonic MDD sample in
this study and, in light of the inverse correlation between
anhedonia and habenula volume, this suggests a possible reason
for the lack of a significant group difference in habenula volume. It
would be of interest in future studies to recruit groups of patients
with specific symptom profiles (for example, with pronounced
melancholic symptoms) to assess whether habenula abnormalities
occur specifically in patients suffering from anhedonia. We note,
however, that habenula volume was not a significant predictor of
fatigue and, interestingly, that fatigue and anhedonia were not
correlated in the MDD group (r= 0.058, P = 0.79). This suggests
that anhedonia (loss of enjoyment or pleasure) uniquely predicts
habenula volume over and above general tiredness, although
both could be considered motivational symptoms.
At present, the microstructure and cellular events that give rise
to grey matter volume as measured by structural MRI remain
poorly understood,46 and future basic research in this area will be
necessary before mechanistic interpretations can be applied to
the correlations discussed above. Interestingly, a recent whole
brain voxel-based morphometry study identified increases
in habenula grey matter volume following treatment with
electroconvulsive therapy in patients with treatment-resistant
depression,47 although we mention this result with the caveat that
an 8 mm smoothing kernel was applied to these data. Although
this study reported no correlation between grey matter volume
and clinical scores, future studies should examine the specific
relationship between grey matter volume and motivational
symptoms during treatment.
Summary
We believe we conducted the first comprehensive investigation of
habenula structure and function in MDD using a computational
psychiatry approach,48 in combination with high-resolution neu-
roimaging. These data support the notion that habenula function is
disrupted in MDD, but not the simple ‘hyperactivity’ hypothesis.
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